The U.S. Food and Drug Administration fully approved Pfizer’s BioNTech vaccine, the first of its kind for Covid-19 vaccine

 On Monday, the U.S. Food and Drug Administration (FDA) fully approved Pfizer and BioNTech’s Covid-19 vaccine-becoming the first in the U.S. to win the coveted designation vaccine and allowing more companies .

schools and universities to use it. Confidence to adopt vaccine directives. So far, the mRNA vaccine that will be sold as Comirnaty is sold on the US market under the emergency use authorization granted by the FDA in December. According to data compiled by the Centers for Disease Control and Prevention, Pfizer has injected more than 204 million injections since then .

Since drug makers submitted applications to the agency in early May, federal health officials have been under increasing pressure from the scientific community and advocacy groups to fully approve Pfizer and BioNTech vaccines. The two companies submitted a biologics license application to the FDA on May 7, which was fully approved for patients 16 years of age and older.

Full article 

Source .